Adapt Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ADAPT, and what generic and branded alternatives to ADAPT drugs are available?
ADAPT has twenty approved drugs.
Summary for Adapt
US Patents: | 0 |
Tradenames: | 18 |
Ingredients: | 18 |
NDAs: | 20 |
Patent Litigation for Adapt: | See patent lawsuits for Adapt |
Drugs and US Patents for Adapt
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 216197-002 | Jul 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adaptis | NAPROXEN | naproxen | TABLET;ORAL | 091416-003 | Feb 14, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adaptis | NAPROXEN | naproxen | TABLET;ORAL | 091416-002 | Feb 14, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 208113-002 | May 17, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adaptis | DUTASTERIDE | dutasteride | CAPSULE;ORAL | 204376-001 | Apr 7, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 216197-001 | Jul 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ADAPT drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Nasal Spray | 4 mg/spray | ➤ Subscribe | 2016-07-15 |